-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
Y-mAbs Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q3 2021 to Q3 2024.
- Y-mAbs Therapeutics, Inc. Operating Margin for the quarter ending September 30, 2024 was -33.7 %, a 32.4% decline year-over-year.
- Y-mAbs Therapeutics, Inc. annual Operating Margin for 2023 was -30.3 %, a 79.2% increase from 2022.
- Y-mAbs Therapeutics, Inc. annual Operating Margin for 2022 was -145 %, a 56.1% increase from 2021.
- Y-mAbs Therapeutics, Inc. annual Operating Margin for 2021 was -331 %, a 42.8% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)